124 related articles for article (PubMed ID: 37311339)
1. Breast cancer missed at screening; hindsight or mistakes?
Hovda T; Larsen M; Romundstad L; Sahlberg KK; Hofvind S
Eur J Radiol; 2023 Aug; 165():110913. PubMed ID: 37311339
[TBL] [Abstract][Full Text] [Related]
2. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
[TBL] [Abstract][Full Text] [Related]
3. Radiological review of prior screening mammograms of screen-detected breast cancer.
Hovda T; Tsuruda K; Hoff SR; Sahlberg KK; Hofvind S
Eur Radiol; 2021 Apr; 31(4):2568-2579. PubMed ID: 33001307
[TBL] [Abstract][Full Text] [Related]
4. Missed and true interval and screen-detected breast cancers in a population based screening program.
Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
[TBL] [Abstract][Full Text] [Related]
6. True and Missed Interval Cancer in Organized Mammographic Screening: A Retrospective Review Study of Diagnostic and Prior Screening Mammograms.
Hovda T; Hoff SR; Larsen M; Romundstad L; Sahlberg KK; Hofvind S
Acad Radiol; 2022 Jan; 29 Suppl 1():S180-S191. PubMed ID: 33926794
[TBL] [Abstract][Full Text] [Related]
7. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography.
Coolen AMP; Lameijer JRC; Voogd AC; Louwman MWJ; Strobbe LJ; Tjan-Heijnen VCG; Duijm LEM
Eur Radiol; 2019 Jan; 29(1):337-344. PubMed ID: 29943181
[TBL] [Abstract][Full Text] [Related]
9. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
[TBL] [Abstract][Full Text] [Related]
10. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
[TBL] [Abstract][Full Text] [Related]
11. Breast cancers missed during screening in a tertiary-care hospital mammography facility.
Waheed KB; Hassan MZU; Hassan DA; Shamrani AAGA; Bassam MA; Elbyali AA; Shams TM; Demiati ZA; Arulanatham ZJ
Ann Saudi Med; 2019; 39(4):236-243. PubMed ID: 31381361
[TBL] [Abstract][Full Text] [Related]
12. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
[TBL] [Abstract][Full Text] [Related]
13. Mammographic features and histopathological findings of interval breast cancers.
Hofvind S; Geller B; Skaane P
Acta Radiol; 2008 Nov; 49(9):975-81. PubMed ID: 18785026
[TBL] [Abstract][Full Text] [Related]
14. Screening-detected breast cancers: discordant independent double reading in a population-based screening program.
Hofvind S; Geller BM; Rosenberg RD; Skaane P
Radiology; 2009 Dec; 253(3):652-60. PubMed ID: 19789229
[TBL] [Abstract][Full Text] [Related]
15. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
16. Screening outcome for interpretation by the first and second reader in a population-based mammographic screening program with independent double reading.
Hovda T; Sagstad S; Larsen M; Chen Y; Hofvind S
Acta Radiol; 2023 Aug; 64(8):2371-2378. PubMed ID: 37246466
[TBL] [Abstract][Full Text] [Related]
17. Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading.
Skaane P; Skjennald A; Young K; Egge E; Jebsen I; Sager EM; Scheel B; Søvik E; Ertzaas AK; Hofvind S; Abdelnoor M
Acta Radiol; 2005 Nov; 46(7):679-89. PubMed ID: 16372686
[TBL] [Abstract][Full Text] [Related]
18. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
19. Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study.
Dembrower K; Wåhlin E; Liu Y; Salim M; Smith K; Lindholm P; Eklund M; Strand F
Lancet Digit Health; 2020 Sep; 2(9):e468-e474. PubMed ID: 33328114
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.
Koch HW; Larsen M; Bartsch H; Kurz KD; Hofvind S
Eur Radiol; 2023 May; 33(5):3735-3743. PubMed ID: 36917260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
